rawfin.tv
UroGen Pharma Files Form 144 on July 9
RegulationstocksAI Generated

UroGen Pharma Files Form 144 on July 9

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

UroGen Pharma Ltd. has filed a Form 144 with the SEC, indicating an intent to sell restricted securities. This technical notification was submitted on July 9th.

URGNForm 144Regulatory FilingBiotech SectorInsider Transactions

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks